ARCHIVES

Vaccine Increases PFS 146%, OS 60% In Phase II Clinical Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

ACS to Purchase $1.5 Million In animal Interferon, Offer it for Laboratory Studies

July 13, 1984

In Brief: Debbie Mayer Elected ONS President; Cullen, Other NCI Staff Honored By Surgeon General

May 15, 1987

DCCP Board Approves Concepts For Three New RFAs, Contract Recompetitions

June 4, 1982

ACS Professors; Connie Mack Is Chairman Of Moffitt Board.

February 9, 2001

NIH Lifts Patient Limit On Gene Modified TIL Study; 6 Treated So Far

April 13, 1990

In Brief: White House Appoints Six to NCAB; Calabrisi To Succeed Korn As Chairman; 2 Spaces Vacant

January 25, 1991